市場調查報告書
商品編碼
1368744
麩醯胺酸市場規模 - 按類型、形式、應用、來源和預測,2023 年至 2032 年Glutamine Market Size - By Type, Form, Application, Source & Forecast, 2023 - 2032 |
麩醯胺酸市場規模預計從 2023 年到 2032 年年複合成長率將達到 3.4%,這主要是由於各行業對必需胺基酸重要性的認知不斷提高。運動員和健身愛好者對營養補充劑的認知很高,他們正在轉向麩醯胺酸,因為它具有肌肉恢復和增強免疫系統的特性。
此外,消費者健康意識的提高導致對含有麩醯胺酸的膳食補充劑的需求不斷成長。根據 NCBI 的數據,2020 年 3 月,英國維生素銷售額成長了 63%。同樣,美國複合維生素的需求也有所成長,同年銷售額達到 51.2%。
麩醯胺酸市場根據類型、形式、來源、應用和地區分類。
預計到 2032 年,D-谷氨醯胺細分市場將出現大幅成長。D-谷氨醯胺是 L-谷氨醯胺的天然立體異構體,由於其在製藥和食品行業的應用而受到廣泛關注。它的特點是具有更高的穩定性和優異的生物利用度,使其成為各種製劑的有吸引力的選擇。隨著製藥和食品行業的不斷擴張,D-谷氨醯胺類細分市場預計將蓬勃發展,以滿足這些行業不斷變化的需求。
由於麩醯胺酸在製藥業中發揮著至關重要的作用,特別是在細胞培養基中以及作為腸外營養產品配方的重要組成部分,預計藥品應用領域將在 2023-2032 年出現顯著成長。它在支持免疫系統和促進組織修復方面的作用使其成為多種藥物中的寶貴成分。隨著藥品研發的不斷推進,預計未來幾年對麩醯胺酸的需求將進一步上升。
受人口老化、醫療保健支出增加和製藥業強勁等因素的推動,到 2032 年,歐洲麩醯胺酸市場規模將獲得巨額收入。此外,歐洲食品安全局 (EFSA) 對與麩醯胺酸在免疫系統中的作用相關的某些健康聲明的認可,增強了其在該地區的吸引力。由於重視健康和保健,歐洲預計將繼續為全球麩醯胺酸市場做出巨大貢獻。
Glutamine market size is expected to record 3.4% CAGR from 2023 to 2032, primarily due to the increased awareness of the importance of essential amino acid in various sectors. There is high awareness about nutritional supplements among athletes and fitness enthusiasts, who are turning to glutamine for its muscle recovery and immune system-boosting properties.
Furthermore, the rising health consciousness among consumers has led to a growing demand for dietary supplements that contain glutamine. According to the NCBI, in UK, the vitamin sales increased by 63% in March 2020. Similarly, the U.S. reported rise in demand for multivitamins as the sales reached 51.2% in the same year.
Glutamine market is divided based on type, form, source, application, and region.
The D-glutamine segment is predicted to witness substantial growth through 2032. D-glutamine, a naturally occurring stereoisomer of L-glutamine, has garnered considerable attention due to its applications in the pharmaceutical and food industries. It is characterized by its higher stability and superior bioavailability, making it an attractive option for various formulations. As the pharmaceutical and food industries continue to expand, the D-glutamine type segment is expected to flourish, catering to the evolving needs of these sectors.
The pharmaceuticals application segment is anticipated to observe significant growth over 2023-2032 as glutamine plays a vital role in the pharmaceutical industry, particularly in cell culture media and as an essential component for the formulation of parenteral nutrition products. Its role in supporting the immune system and facilitating tissue repair has made it a valuable ingredient in a variety of medications. As pharmaceutical R&D continue to advance, the demand for glutamine is anticipated to rise further in the coming years.
Europe glutamine market size will gain massive revenues by 2032, driven by factors such as a growing aging population, increased healthcare expenditure, and a strong pharmaceutical sector. Additionally, the European Food Safety Authority's (EFSA) recognition of certain health claims related to glutamine's role in the immune system has heightened its appeal in the region. With an emphasis on health and wellness, Europe is expected to continue its substantial contribution to the global glutamine market.